These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33012458)

  • 61. Understanding Gaps in the Hepatocellular Carcinoma Cascade of Care: Opportunities to Improve Hepatocellular Carcinoma Outcomes.
    Wong RJ; Ahmed A;
    J Clin Gastroenterol; 2020; 54(10):850-856. PubMed ID: 33030855
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature.
    Piardi T; Memeo R; Renard Y; Ammendola M; Bruno O; Habersetzer F; Baumert T; Pessaux P; Sommacale D
    Minerva Chir; 2016 Jun; 71(3):192-200. PubMed ID: 26883849
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments.
    Kassahun WT
    World J Surg Oncol; 2016 May; 14(1):151. PubMed ID: 27215576
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
    Verslype C; Van Cutsem E; Dicato M; Arber N; Berlin JD; Cunningham D; De Gramont A; Diaz-Rubio E; Ducreux M; Gruenberger T; Haller D; Haustermans K; Hoff P; Kerr D; Labianca R; Moore M; Nordlinger B; Ohtsu A; Rougier P; Scheithauer W; Schmoll HJ; Sobrero A; Tabernero J; van de Velde C
    Ann Oncol; 2009 Jun; 20 Suppl 7():vii1-vii6. PubMed ID: 19497945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatocellular carcinoma: Present and future.
    Armengol C; Sarrias MR; Sala M
    Med Clin (Barc); 2018 May; 150(10):390-397. PubMed ID: 29096967
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New challenges in clinical research on hepatocellular carcinoma.
    Díaz-González Á; Forner A; Rodríguez de Lope C; Varela M
    Rev Esp Enferm Dig; 2016 Aug; 108(8):485-93. PubMed ID: 26653993
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multimodal treatment of hepatocellular carcinoma.
    Graf D; Vallböhmer D; Knoefel WT; Kröpil P; Antoch G; Sagir A; Häussinger D
    Eur J Intern Med; 2014 Jun; 25(5):430-7. PubMed ID: 24666568
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Current approaches to the diagnosis and management of hepatocellular carcinoma.
    Perry JF; Poustchi H; George J; Farrell GC; McCaughan GW; Strasser SI
    Clin Exp Med; 2005 May; 5(1):1-13. PubMed ID: 15928877
    [TBL] [Abstract][Full Text] [Related]  

  • 69. AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma.
    Dixon E; Abdalla E; Schwarz RE; Vauthey JN
    HPB (Oxford); 2010 Jun; 12(5):287-8. PubMed ID: 20590900
    [No Abstract]   [Full Text] [Related]  

  • 70. Contrasting Some Differences in Managing Advanced Unresectable Hepatocellular Carcinoma Between the East and the West.
    Lee VHF; Seong J; Yoon SM; Wong TCL; Wang B; Zhang JL; Chiang CL; Ho PPY; Dawson LA
    Clin Oncol (R Coll Radiol); 2019 Aug; 31(8):560-569. PubMed ID: 31279433
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatocellular carcinoma: beyond the boundaries of age.
    Di Benedetto F; Tarantino G; Quintini C; Tirelli U; Berretta M
    Anticancer Agents Med Chem; 2013 Nov; 13(9):1371-7. PubMed ID: 24102284
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systemic adjuvant treatment in hepatocellular carcinoma: tempted to do something rather than nothing.
    Rizzo A; Ricci AD; Brandi G
    Future Oncol; 2020 Nov; 16(32):2587-2589. PubMed ID: 32772560
    [No Abstract]   [Full Text] [Related]  

  • 73. Medical Management of Hepatocellular Carcinoma.
    Rich NE; Yopp AC; Singal AG
    J Oncol Pract; 2017 Jun; 13(6):356-364. PubMed ID: 28605614
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.
    Fong ZV; Tanabe KK
    Cancer; 2014 Sep; 120(18):2824-38. PubMed ID: 24897995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations.
    Sangiovanni A; Triolo M; Iavarone M; Forzenigo LV; Nicolini A; Rossi G; La Mura V; Colombo M; Lampertico P
    Liver Int; 2018 Sep; 38(9):1624-1634. PubMed ID: 29791968
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Management of patients with hepatocellular carcinoma and extrahepatic metastasis.
    Lee HS
    Dig Dis; 2011; 29(3):333-8. PubMed ID: 21829026
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma.
    Byrd K; Alqahtani S; Yopp AC; Singal AG
    Semin Liver Dis; 2021 Jan; 41(1):1-8. PubMed ID: 33764480
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma.
    Chen M; Therneau T; Orsini LS; Qiao YL
    BMC Gastroenterol; 2011 May; 11():53. PubMed ID: 21569429
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interventional radiology in the multidisciplinary management of liver lesions: pre- and postoperative roles.
    Ward TJ; Madoff DC; Weintraub JL
    Semin Liver Dis; 2013 Aug; 33(3):213-25. PubMed ID: 23943102
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.